Skip to main content

Table 3 Cohort averages and statistical significance results for the wearable metrics

From: A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)

Mean (Median) M0-M1 M1-M2 M2-M3 M3-M4 M4-M5 M5-M6 Overall Cohort Mean (Median)
[range]
Wilcoxon p-value
ADM 1171.6 (1063.2) 1183.2 (954.1) 952.0 (893.7) 1094.1 (935.9) 1011.3 (1065.6) 943.5 (811.1) 1059.6 (962.3) [684 to 1625] 0.10
ADS 6902.7 (6452.9) 6850.6 (6867.9) 7825.7 (7068.2) 8431.5 (6525.0) 7317.2 (5955.8) 6346.6 (4971.1) 7253.2 (6526.9) [2532 to 16,315] 0.51
ADE 288.9 (240.8) 264.2 (208.3) 272.8 (236.0) 277.8 (238.4) 260.0 (281.8) 259.5 (246.3) 270.6 (235.8) [125 to 475] 0.80
  1. ADM Average daily maximum, ADS Average daily steps, ADE Average daily steps per 30-min epoch. M month